Cardinal Health gains on CVS distribution deal extension

By Reuters News

** Healthcare services company Cardinal Health CAH.N gains 3.8% to $231.13

** Co enters binding letter of intent to extend pharmaceutical distribution agreements with healthcare company CVS Health CVS.N through June 2032

** The deal maintains CAH's existing distribution services for CVS Health

** Co reaffirms fiscal 2027 adj. EPS growth of 13%-15%, with a forecast of $12.40-$12.60 per share

** CAH also reaffirms its long-term adjusted EPS growth target of 12%-14%

** CAH shares up nearly 14% YTD

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk